Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.
HBD. Yout comment on costs is another reason I think this will be a short term deal. It's like flipping a house, you buy and have to prove you can pay but you only pay the mortgage for the time you own it. Buy it, refurb, then sell it on. I think that's what is happening hear. Other than some relatively small trial start up costs and salaries, there is very little risk when compared to the potential upside. I still think a successful p2 737 combo trail would see the 737 value around £800 million. As other's have said here, it wouldn't surprise me if a spinoff company has been setup, just for this purpose. Hire the SO team who worked on 737 and off you go. The shares highlighted in the RNS, would only come into play if the company suddenly jumps in value (ahem, takeover). Tax deductible if it fails.
I'd put money on the new licence being purely for validation reasons. It's almost identical to the SO license but now has the shares. I'm calling it now the private pharma will validate 737 in combo, with a small p2 trial or maybe even a 1b trial. Then once they have data that validates further trials, it will be put up for sale. The shares are an insurance policy for this scenario. 12 to 18 months. The only downside to this is timescales. IMO, there won't be anything tangible that will rerate SAR in 2024. We will get good news in 2024, hopefully but the RF facility will eat up any gains until 1801 1b data is ready. I'll keep buying this year and will probably trade the spikes but it'll be 2025 before we see us back near the highs we once saw.
It's obvious that the big players need proof of 737 with combo efficacy. This deal gives them a fast track way to data and IMO, it will be sold on good data. That's where these shares will come into play and the wording on the RNS suggests that it could be within 12 months. Possibly in time to pay for 1801 P2.
You missed something. The original deal for the preclinical chk1 back in 2016 was worth more than the phase 2 ready 737 deal announced yesterday. You have to laugh about it. AIM never made sense to me. You'd do just as well finding 20 100 to 1 shot horses and sticking £1k on each. Potential returns are huge and it'll be over very quickly if you lose.
Not a negative post. Your post made me 😂.
Yes, Aber. It's a curious choice of words. We know we have funding until the end of p1b. This is likley to be 2025 for the data readout. That will be way before 737 pays us anything significant. I think Tim is referring to the shares we "could" be issued within 12 months. That timeline would work in this scenario. My only negative thought on this is, it's the usual, more questions than answers we've come to expect from SAR. Good that it's progressing but SAR carry all the risk.
Yes, went back and read it properly. We've no idea how much those shares are worth until we know the company and how many shares they have in issue but like I said, it could be lucrative if the company sells up. I
Also, unless someone can find a corresponding news item in the US, I think this company is private as you can't just give away shares without notifying the market. Some of the shares could be issued within 12 months so, I think that is our timeline for the next bit of 737 news, also the reason why the trading is quiet. Good news but more waiting.
It's, practically the same deal, Silver. Good news as it a moving again but it won't set the world on fire. We'll get a small upfront but it doesn't solve our mid term finance issues so we are stuck with RF until an 1801 licence. The deal seems undervalued to me, probably with a small biotech. It's the 500k shares. Big pharma, don't give away that amount of shares. I think it's with a company like Sierra who will take the compound through p2 combo and then sell up. Do we get 27% of the 500k shares? Because that could be lucrative in the event if a buyout.
Haven't got an agenda. I'm buying because I hope 737 news will come before we start to run out of cash. You know what I find weird. Posters who research what other posters post. I mean, why would you waist your time? Is it to try and discredit.? Who cares what I think? You are just parroting (no pun intended) the the theory that posters with negative views have an agenda. If only it was that easy to steer the direction of travel.
Aye, Gus. We are all here to make money or at the very least, not lose money. Imagine a board where all views were given a chance to be aired. Take out the emotional attachment to company and it's easier to make a decision about whether to hold or sell. Said this before, Thoth saved me a big chunk of money once and he didn't even know. Id been watching IMM for a bit, they were due p3 news and the rampers were saying it woukd 10 bag, I actually think they believed that but that's by the by. Anyway, I was watching and reading the chat and maybe a, week before news dropped, Thoth turned up and started saying he thought they fd up the trial design and he couldn't see it progressing. As you can imagine, he got absolutely slated and it was a big pile on from the IMM LTH. I didn't buy in and news dropped, it was bad, 90% wiped of the SP overnight. I followed the chat after the news too. So I had a before and after view of the debacle. It was at that point where I saw the similarities with IMM and Sareum. The way the so called LTH tried to police the posts so that only positive posts were given and heard. Trouble is apart from the shorters, everyone lost. I looked at every one of my holdings a different way after that.
Worse than that, Blue. They were being ridiculed when suggesting the sp would fall below 6p (£3) then 3p (£1.50). When you look back with hindsight, the "Wombles" were the good guys who got the SP prediction calls right. For the record, I feel positive about my investment here but there is nothing more triggering than when a so called LTH tries to silence any poster who questions the positive narrative. Thinking of Puma here, when they said to check other stock where RF had been involved. I did and was initially in denial but as it turned out, they were correct. Big lesson learned for me. To end on a positive, early pay this week so I will buy more.
I'd agree with that but with RF hanging around. It's in their interest to keep the SP lower that the original offer. They keep getting shares until they have their £2.6 million back. The only thing that could work in theirs and our favour is, if the SP jumps significantly but we are talking 100% to here type jumps. 737 news could do it
They have more or less stated that no licence or indeed a buyout will happen until p1b data is back. So I'm not sure if moving Tim sideways will do anything for us. The science is essentially done. It's too late in the day to make any big chsnges. If 1b data is good, we'll get a licence, if not, we are screwed. Tim and Stephen p need to focus their time on securing the mid term funding needed so we aren't reduced to looking down the back of the sofa this time next year.
I'm still if the opinion that the board are hoping 737 will rescue us before the cash runs out. The RNS, for was expected as us the drop and the next tranche of drawdown due in Feb 24. We know its going to happen and we need the cash. So we all should be prepared to watch the SP keep falling until tangible news. I'm OK with all that, I have made my peace with it but at times, this LSE board is it's own worst enemy. Loads of posters thinking something different is going to happen contrary to what we have been told via RNS. If 1a data is good, they need to shout it from the rooftops and as we won't get 1b data until 2025.
I don't think we have a bad board, I just think they have been a little naive and failed to plan and have contingency in place. The blame can't all be pointed at MHRA. We were already behind schedule at the start of the pandemic. I appreciate they can't give a running commentary but we just need focus now. We haven't had the AGM results RNS yet. I wonder if it's the done thing to address sentiment in that RNS. We should get it today.
Ha ha, Baton. It's all good, I mean, I'm OK with the RNS, it's as I expected. And if RF are selling, I expected that as well, said it last week. Let the sp drop and I'll buy some more and I'll keep buying until some sort of news. And in true Potnak style, even though I'll buy more, that doesn't mean I am happy with how the board have managed this company over the last 5 years.
It's the same message just different words, Warty. I presume 1a data readout is still H124 and if P2 completes in 24 then the data readout for 1b will be H1 25. We did know this but I think some here choose to believe something else.